                         SEQUENCE LISTING

<110>  CERAPEDICS, INC.
 
<120>  PEPTIDE-COATED CALCIUM PHOSPHATE PARTICLES

<130>  50517-027WO2

<140>  PCT/US17/43614
<141>  2017-07-25

<150>  62/366,370
<151>  2016-07-25

<160>  21    

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  1

Gly Thr Pro Gly Pro Gln Gly Ile Ala Gly Gln Arg Gly Val Val 
1               5                   10                  15  


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  2

Gly Pro Gln Gly Ile Ala Gly Gln Arg 
1               5                   


<210>  3
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  3

Gln Gly Ile Ala Gly Gln 
1               5       


<210>  4
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  4

Gln Gly Ile Ala Gly Gln Arg 
1               5           


<210>  5
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  5

Phe Gly Ile Ala Gly Phe 
1               5       


<210>  6
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  6

Gly Ile Ala Gly Gln 
1               5   


<210>  7
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  7

Gln Gly Ala Ile Ala Gln 
1               5       


<210>  8
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  8

Phe Gly Ile Ala Gly Phe 
1               5       


<210>  9
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  9

Cys Gly Ile Ala Gly Cys 
1               5       


<210>  10
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  10

Glu Gly Ile Ala Gly Lys 
1               5       


<210>  11
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  ACETYLATION
<222>  (1)..(1)
<223>  N-acetyl Isoleucine

<400>  11

Ile Ala Ala 
1           


<210>  12
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  beta.Ala

<400>  12

Ile Ala Ala 
1           


<210>  13
<211>  2
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  ACETYLATION
<222>  (1)..(1)
<223>  N-acetyl Isoleucine

<220>
<221>  METHYLATION
<222>  (2)..(2)
<223>  alanyl-methylamide

<400>  13

Ile Ala 
1       


<210>  14
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  14

Asp Gly Glu Ala 
1               


<210>  15
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  15

Asp Gly Glu Ala Gly Cys 
1               5       


<210>  16
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is hydroxyproline

<400>  16

Gly Phe Xaa Gly Glu Arg 
1               5       


<210>  17
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is hydroxyproline

<400>  17

Gly Leu Xaa Gly Glu Arg 
1               5       


<210>  18
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is hydroxyproline

<400>  18

Gly Met Xaa Gly Glu Arg 
1               5       


<210>  19
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  19

Gly Ala Ser Gly Glu Arg 
1               5       


<210>  20
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  20

Gly Leu Ser Gly Glu Arg 
1               5       


<210>  21
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is hydroxyproline

<400>  21

Gly Ala Xaa Gly Glu Arg 
1               5       


